MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice. (Q50792869)
Jump to navigation
Jump to search
scientific article published on 27 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice. |
scientific article published on 27 July 2012 |
Statements
MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice (English)
Ha-Neui Kim
Jong-Ho Lee
Sungjin Ko
Kyoungsuk Jung